Stenting and Angioplasty in Neurothrombectomy: Matched Analysis of Rescue Intracranial Stenting Versus Failed Thrombectomy.


Journal

Stroke
ISSN: 1524-4628
Titre abrégé: Stroke
Pays: United States
ID NLM: 0235266

Informations de publication

Date de publication:
09 2022
Historique:
pubmed: 1 7 2022
medline: 25 8 2022
entrez: 30 6 2022
Statut: ppublish

Résumé

Successful reperfusion is one of the strongest predictors of functional outcomes after mechanical thrombectomy (MT). Despite continuous advancements in MT technology and techniques, reperfusion failure still occurs in ≈15% to 30% of patients with large vessel occlusion strokes undergoing MT. We aim to evaluate the safety and efficacy of rescue intracranial stenting for large vessel occlusion stroke after failed MT. The SAINT (Stenting and Angioplasty in Neurothrombectomy) Study is a retrospective analysis of prospectively collected data from 14 comprehensive stroke centers through January 2015 to December 2020. Patients were included if they had anterior circulation large vessel occlusion stroke due to intracranial internal carotid artery and middle cerebral artery-M1/M2 segments and failed MT. The cohort was divided into 2 groups: rescue intracranial stenting and failed recanalization (modified Thrombolysis in Cerebral Ischemia score 0-1). Propensity score matching was used to balance the 2 groups. The primary outcome was the shift in the degree of disability as measured by the modified Rankin Scale at 90 days. Secondary outcomes included functional independence (90-day modified Rankin Scale score 0-2). Safety measures included symptomatic intracranial hemorrhage and 90-day mortality. A total of 499 patients were included in the analysis. Compared with the failed reperfusion group, rescue intracranial stenting had a favorable shift in the overall modified Rankin Scale score distribution (acOR, 2.31 [95% CI, 1.61-3.32]; Acute intracranial stenting appears to be a safe and effective rescue strategy in patients with large vessel occlusion stroke who failed MT. Randomized multicenter trials are warranted.

Sections du résumé

BACKGROUND
Successful reperfusion is one of the strongest predictors of functional outcomes after mechanical thrombectomy (MT). Despite continuous advancements in MT technology and techniques, reperfusion failure still occurs in ≈15% to 30% of patients with large vessel occlusion strokes undergoing MT. We aim to evaluate the safety and efficacy of rescue intracranial stenting for large vessel occlusion stroke after failed MT.
METHODS
The SAINT (Stenting and Angioplasty in Neurothrombectomy) Study is a retrospective analysis of prospectively collected data from 14 comprehensive stroke centers through January 2015 to December 2020. Patients were included if they had anterior circulation large vessel occlusion stroke due to intracranial internal carotid artery and middle cerebral artery-M1/M2 segments and failed MT. The cohort was divided into 2 groups: rescue intracranial stenting and failed recanalization (modified Thrombolysis in Cerebral Ischemia score 0-1). Propensity score matching was used to balance the 2 groups. The primary outcome was the shift in the degree of disability as measured by the modified Rankin Scale at 90 days. Secondary outcomes included functional independence (90-day modified Rankin Scale score 0-2). Safety measures included symptomatic intracranial hemorrhage and 90-day mortality.
RESULTS
A total of 499 patients were included in the analysis. Compared with the failed reperfusion group, rescue intracranial stenting had a favorable shift in the overall modified Rankin Scale score distribution (acOR, 2.31 [95% CI, 1.61-3.32];
CONCLUSIONS
Acute intracranial stenting appears to be a safe and effective rescue strategy in patients with large vessel occlusion stroke who failed MT. Randomized multicenter trials are warranted.

Identifiants

pubmed: 35770672
doi: 10.1161/STROKEAHA.121.038248
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2779-2788

Auteurs

Mahmoud H Mohammaden (MH)

Department of Neurology, Marcus Stroke & Neuroscience Center, Grady Memorial Hospital, Emory University School of Medicine-Atlanta, GA (M.H.M., D.C.H.).

Diogo C Haussen (DC)

Department of Neurology, Marcus Stroke & Neuroscience Center, Grady Memorial Hospital, Emory University School of Medicine-Atlanta, GA (M.H.M., D.C.H.).

Alhamza R Al-Bayati (AR)

UPMC Stroke Institute, Departments of Neurology and Neurosurgery, University of Pittsburgh School of Medicine, PA (A.R.A.-B., O.K., B.A.G., M.J.L., S.N., R.G.N.).

Ameer Hassan (A)

Department of Neurology, Valley Baptist Medical Center, Harlingen, TX (A.H., W.T.).

Wondwossen Tekle (W)

Department of Neurology, Valley Baptist Medical Center, Harlingen, TX (A.H., W.T.).

Johanna Fifi (J)

Department of Neurology, Icahn School of Medicine at Mount Sinai, New York (J.F., S.M.).

Stavros Matsoukas (S)

Department of Neurology, Icahn School of Medicine at Mount Sinai, New York (J.F., S.M.).

Okkes Kuybu (O)

UPMC Stroke Institute, Departments of Neurology and Neurosurgery, University of Pittsburgh School of Medicine, PA (A.R.A.-B., O.K., B.A.G., M.J.L., S.N., R.G.N.).

Bradley A Gross (BA)

UPMC Stroke Institute, Departments of Neurology and Neurosurgery, University of Pittsburgh School of Medicine, PA (A.R.A.-B., O.K., B.A.G., M.J.L., S.N., R.G.N.).

Michael J Lang (MJ)

UPMC Stroke Institute, Departments of Neurology and Neurosurgery, University of Pittsburgh School of Medicine, PA (A.R.A.-B., O.K., B.A.G., M.J.L., S.N., R.G.N.).

Sandra Narayanan (S)

UPMC Stroke Institute, Departments of Neurology and Neurosurgery, University of Pittsburgh School of Medicine, PA (A.R.A.-B., O.K., B.A.G., M.J.L., S.N., R.G.N.).

Gustavo M Cortez (GM)

Lyerly Neurosurgery, Baptist Medical Center Downtown, Jacksonville, FL (G.M.C., R.A.H., A.A., E.S.).

Ricardo A Hanel (RA)

Lyerly Neurosurgery, Baptist Medical Center Downtown, Jacksonville, FL (G.M.C., R.A.H., A.A., E.S.).

Amin Aghaebrahim (A)

Lyerly Neurosurgery, Baptist Medical Center Downtown, Jacksonville, FL (G.M.C., R.A.H., A.A., E.S.).

Eric Sauvageau (E)

Lyerly Neurosurgery, Baptist Medical Center Downtown, Jacksonville, FL (G.M.C., R.A.H., A.A., E.S.).

Mudassir Farooqui (M)

Department of Neurology, University of Iowa Hospitals and Clinics, Iowa City (M.F., S.O.-G., C.Z., M.G.-C.).

Santiago Ortega-Gutierrez (S)

Department of Neurology, University of Iowa Hospitals and Clinics, Iowa City (M.F., S.O.-G., C.Z., M.G.-C.).

Cynthia Zevallos (C)

Department of Neurology, University of Iowa Hospitals and Clinics, Iowa City (M.F., S.O.-G., C.Z., M.G.-C.).

Milagros Galecio-Castillo (M)

Department of Neurology, University of Iowa Hospitals and Clinics, Iowa City (M.F., S.O.-G., C.Z., M.G.-C.).

Sunil A Sheth (SA)

Department of Neurology, University of Texas, Houston (S.A.S., M.N., S.S.-M.).

Michael Nahhas (M)

Department of Neurology, University of Texas, Houston (S.A.S., M.N., S.S.-M.).

Sergio Salazar-Marioni (S)

Department of Neurology, University of Texas, Houston (S.A.S., M.N., S.S.-M.).

Thanh N Nguyen (TN)

Department of Neurology, Radiology, Boston University School of Medicine, MA (T.N.N., M.A., P.K.).

Mohamad Abdalkader (M)

Department of Neurology, Radiology, Boston University School of Medicine, MA (T.N.N., M.A., P.K.).

Piers Klein (P)

Department of Neurology, Radiology, Boston University School of Medicine, MA (T.N.N., M.A., P.K.).

Muhammad Hafeez (M)

Department of Neurosurgery, Baylor School of Medicine, Houston, TX (M.H., P.K., O.T.).

Peter Kan (P)

Department of Neurosurgery, Baylor School of Medicine, Houston, TX (M.H., P.K., O.T.).

Omar Tanweer (O)

Department of Neurosurgery, Baylor School of Medicine, Houston, TX (M.H., P.K., O.T.).

Ahmad Khaldi (A)

Department of Neurosciences, WellStar Health System, Atlanta, GA (A.K., H.L.).

Hanzhou Li (H)

Department of Neurosciences, WellStar Health System, Atlanta, GA (A.K., H.L.).

Mouhammad Jumaa (M)

Department of Neurology, University of Toledo, OH (M.J., S.Z., M.O.).

Syed Zaidi (S)

Department of Neurology, University of Toledo, OH (M.J., S.Z., M.O.).

Marion Oliver (M)

Department of Neurology, University of Toledo, OH (M.J., S.Z., M.O.).

Mohamed M Salem (MM)

Department of Neurosurgery, University of Pennsylvania, Philadelphia (M.M.S., J.-K.B., B.A.P.).

Jan-Karl Burkhardt (JK)

Department of Neurosurgery, University of Pennsylvania, Philadelphia (M.M.S., J.-K.B., B.A.P.).

Bryan A Pukenas (BA)

Department of Neurosurgery, University of Pennsylvania, Philadelphia (M.M.S., J.-K.B., B.A.P.).

Ali Alaraj (A)

Department of Neurosurgery, University of Illinois at Chicago (A.A., S.P.).

Sophia Peng (S)

Department of Neurosurgery, University of Illinois at Chicago (A.A., S.P.).

Rahul Kumar (R)

Department of Neurology, Cooper University Medical Center, Camden, NJ (R.K., M.L., J.S.).

Michael Lai (M)

Department of Neurology, Cooper University Medical Center, Camden, NJ (R.K., M.L., J.S.).

James Siegler (J)

Department of Neurology, Cooper University Medical Center, Camden, NJ (R.K., M.L., J.S.).

Raul G Nogueira (RG)

UPMC Stroke Institute, Departments of Neurology and Neurosurgery, University of Pittsburgh School of Medicine, PA (A.R.A.-B., O.K., B.A.G., M.J.L., S.N., R.G.N.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH